US Researchers Barred from WHO Talks

The Trump administration has restricted direct communication between key U.S. infectious disease researchers and the World Health Organization (WHO) during ongoing virus outbreaks, according to internal Health and Human Services (HHS) agency communications and sources. This policy, implemented by Institute of Allergy and Infectious Diseases (NIAID), has limited U.S. participation in global discussions on outbreaks such as hantavirus and Ebola as of May 2026.

Under the directive, NIAID staff, including those from the agency previously led by Dr. Anthony Fauci, were initially prohibited from direct contact with the WHO. While some restrictions were eased in May 2026, allowing limited attendance at virtual WHO meetings, participation remains in a "listening capacity" only, with follow-up handled by HHS. This approach has been criticized by current and former health officials for hindering rapid international cooperation during public health emergencies.

The communication limitations coincide with a broader U.S. disengagement from global health forums, including the U.S. withdrawal from the WHO in January 2026. Additionally, several top health positions within the U.S. government, such as the director of NIAID, Surgeon General, and head of the Food and Drug Administration, remain vacant, contributing to a leadership vacuum during these public health crises.